Carbutamide

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 2605:e000:8789:d800:450:68ef:627d:1060 (talk) at 12:49, 24 August 2016. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Carbutamide
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
ATC code
Identifiers
  • 4-amino-N-(butylcarbamoyl)benzenesulfonamide
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.005.841 Edit this at Wikidata
Chemical and physical data
FormulaC11H17N3O3S
Molar mass271.335 g/mol g·mol−1
3D model (JSmol)
  • O=S(=O)(c1ccc(N)cc1)NC(=O)NCCCC
  • InChI=1S/C11H17N3O3S/c1-2-3-8-13-11(15)14-18(16,17)10-6-4-9(12)5-7-10/h4-7H,2-3,8,12H2,1H3,(H2,13,14,15) ☒N
  • Key:VDTNNGKXZGSZIP-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Carbutamide (brand name Glucidoral) is an anti-diabetic drug of the sulfonylurea class, developed by Servier.

It is classified as first-generation.[1]

References

  1. ^ Ballagi-Pordány G, Köszeghy A, Koltai MZ, Aranyi Z, Pogátsa G (January 1990). "Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds". Diabetes Res. Clin. Pract. 8 (2): 109–14. doi:10.1016/0168-8227(90)90020-T. PMID 2106423.